Japanese companies make cautious return to Indian pharma market

MUMBAI: After burning their fingers more than once in India with troubled acquisitions, Japanese drug makers are back in this market, this time through the age-old route of product launches.

Japanese companies received the highest number of drug approvals from the Drug Controller General of India in 2016, beating their American and Swiss counterparts. Out of the 20 approvals that came in the past year, five went to four Japanese companies: Eisai, Takeda, Dainippon etc

naltrexone rheumatoid arthritis click side effects of naltrexone
naltrexone contraindications site what is vivitrol used for
naltrexone pain management site what happens if you take naltrexone and opiates

1/4/2017 4:14:40 PM